• LAST PRICE
    0.0001
  • TODAY'S CHANGE (%)
    0.0000 (0.0000%)
  • Bid / Lots
    ---/ ---
  • Ask / Lots
    ---/ ---
  • Open / Previous Close
    0.0000 / 0.0001
  • Day Range
    ---
  • 52 Week Range
    Low 0.0001
    High 0.0001
  • Volume
    ---

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
CompanyCountrySymbol
Select an index
Price Comparison Graph. See accessible table below
Table Data Not Available
Data delayed at least 15 minutes.
No documents available
0 New Today
Industry Peers Overview Table
Company sortableMarket Cap sortableP/E Ratio (TTM) sortableEPS Growth (5yr) sortable
United StatesOMMH
Omnimmune Holdings Inc
940.0
0.0x
---
United StatesNTME
Netmed Inc
190.0
0.0x
---
United StatesEAPH
Easton Pharmaceuticals Inc
1.3K
0.0x
---
United StatesLIFS
Life Stem Genetics Inc
27.5K
0.0x
---
United StatesANTH
Anthera Pharmaceuticals Inc
2.6K
0.0x
---
United StatesPZRXQ
PZ Wind Down Inc
1.2K
0.0x
---
As of 2023-03-25

Company Information

Omnimmune Holdings, Inc. (Omnimmune) is a development-stage biotechnology company integrating complementary cancer therapeutic, diagnostic and prognostic technologies. The Company is the holding company of Omnimmune Corp. Omnimmune has acquired licensed rights to diagnostic and platform monoclonal antibody technologies. Omnimmune‚Äôs hCGß and related technologies, which are protected through an expanding intellectual property portfolio, have been developed at institutions including Columbia University of New York, New York (Columbia), The Allegheny-Singer Research Institute of the West Penn Allegheny Health System, Pittsburgh, Pennsylvania (Allegheny) and The Institute Gustave Roussy, Paris, France (IGR).

Contact Information

Headquarters
4600 Post Oak Place Dr Ste 352HOUSTON, TX, United States 77027-9608
Phone
713-622-8400
Fax
302-655-5049

Executives

Chief Executive Officer, Director
Travis McPhee

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals Table
Market Cap
$940.00
Revenue (TTM)
$0.00
Shares Outstanding
9.4M
Dividend Yield
0.00%
Annual Dividend Rate
---
Ex-Dividend Date
01-01-01
Pay Date
01-01-01
Beta
---
EPS
$-0.20
Book Value
$-0.61
P/E Ratio
0.0x
Price/Sales (TTM)
---
Price/Cash Flow (TTM)
---
Operating Margin
---
*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.